These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 769632)
1. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Shull HJ; Wilkinson GR; Johnson R; Schenker S Ann Intern Med; 1976 Apr; 84(4):420-5. PubMed ID: 769632 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of oxazepam and lorazepam. Greenblatt DJ Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408 [TBL] [Abstract][Full Text] [Related]
3. The effect of liver disease in man on the disposition of phenobarbital. Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636 [TBL] [Abstract][Full Text] [Related]
4. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives. Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698 [TBL] [Abstract][Full Text] [Related]
5. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam. Patel M; Tang BK; Grant DM; Kalow W Pharmacogenetics; 1995 Oct; 5(5):287-97. PubMed ID: 8563769 [TBL] [Abstract][Full Text] [Related]
6. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104 [TBL] [Abstract][Full Text] [Related]
7. Effects of liver disease and of aging on the disposition and elimination of sedatives. Schenker S Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206 [No Abstract] [Full Text] [Related]
13. Disposition of oxazepam in patients on maintenance hemodialysis. Ochs HR; Greenblatt DJ; Klehr U Klin Wochenschr; 1984 Aug; 62(16):765-7. PubMed ID: 6482312 [TBL] [Abstract][Full Text] [Related]
14. The effects of age and chronic liver disease on the elimination of temazepam. Ghabrial H; Desmond PV; Watson KJ; Gijsbers AJ; Harman PJ; Breen KJ; Mashford ML Eur J Clin Pharmacol; 1986; 30(1):93-7. PubMed ID: 2872062 [TBL] [Abstract][Full Text] [Related]
15. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man. Wilkinson GR Acta Psychiatr Scand Suppl; 1978; (274):56-74. PubMed ID: 32740 [No Abstract] [Full Text] [Related]
16. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate. Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915 [TBL] [Abstract][Full Text] [Related]
17. Effects of liver disease on the disposition of ciramadol in humans. Hoyumpa AM; Brown MW; Johnson R; Troxell R; Snowdy P; Schenker S J Clin Pharmacol; 1989 Mar; 29(3):217-24. PubMed ID: 2723108 [TBL] [Abstract][Full Text] [Related]
18. Cimetidine spares the glucuronidation of lorazepam and oxazepam. Patwardhan RV; Yarborough GW; Desmond PV; Johnson RF; Schenker S; Speeg KV Gastroenterology; 1980 Nov; 79(5 Pt 1):912-6. PubMed ID: 6106621 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic profile of oxazepam. Alván G; Odar-Cederlöf I Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777 [TBL] [Abstract][Full Text] [Related]
20. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. Abernethy DR; Greenblatt DJ; Divoll M; Shader RI J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]